Emergency Medicine

HIV / AIDS

Medical News

Primary Care

Surgery

Home » Archive by Category

Articles in the Medical News Category

BD Diagnostics Launches The BD Protect(TM) Infection Surveillance And Prevention Software Portfolio
Saturday, 20 Mar, 2010 – 2:00 | No Comment

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced the launch of the BD Protect™ Infection Surveillance and Data Management System, a portfolio of healthcare management software solutions that tracks infections and helps prevent their transmission at three levels — from patient to patient, between patients and healthcare workers, and from community sources to healthcare settings…

Physicians Practice And All Children’s Hospital To Improve Patient Care In St. Petersburg, FL
Saturday, 20 Mar, 2010 – 2:00 | No Comment

Physicians Practice and All Children’s Hospital have joined forces to help provide area physicians and their staff more time to devote to patient care. This new partnership is a unique program designed to help doctors in the St. Petersburg area better handle the cumbersome and time-consuming issues of managing a busy practice. Through this new alliance, All Children’s Hospital will use Physicians Practice’s extensive resources to deliver essential practice management tools to help local physicians manage the business aspects of medicine more efficiently and effectively…

Slo-Niacin(R), A Non-Prescription Dietary Supplement, Features Nicotinic Acid - The Most Effective Agent For Increasing HDL, ‘Good Cholesterol’
Saturday, 20 Mar, 2010 – 2:00 | No Comment

Niacin, or nicotinic acid, when used under the care and monitoring of a healthcare provider, is the most effective agent available for increasing high-density lipoprotein (HDL), or “good cholesterol (1).” HDL is known as “good cholesterol” because it has protective effects on the heart and blood vessels. It not only removes excess cholesterol in the blood and brings it to the liver for disposal, it may also have antioxidant, anti-inflammatory and anti-clotting effects (2). Some experts also believe that HDL removes excess cholesterol from arterial plaque, slowing its buildup (3)…

Prometheus And Bayer Schering Pharma To Apply Novel Diagnostic Platform To Oncology Therapeutic Candidates
Saturday, 20 Mar, 2010 – 2:00 | No Comment

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus’ proprietary oncology diagnostic platform with Bayer’s broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products…

Early Identification Of Alzheimer’s Disease With PET Scan
Saturday, 20 Mar, 2010 – 2:00 | No Comment

Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer’s in its early more treatable phase. According to Dr…

Cystodistension: No Standards And No Benefits-Survey Of UK Practice - When Data Is Limited, The Place Of Hydrodistention And Hunner’s Lesion Ablation
Saturday, 20 Mar, 2010 – 1:00 | No Comment

UroToday.com - Cystoscopy with hydrodistention is not practiced in any standardized fashion despite proposals by the National Institute of Diabetes Digestive and Kidney Disorders (NIDDK) 2 decades ago and more recently the European Society for the Study of Interstitial Cystitis (ESSIC) to establish such standards. Mahendru and Al-Taher from Colchester and Kings Lynn UK posted questionnaires to 486 Consultant gynecologists, and urologists in the UK to assess current practices…

Accelerating The Pace Of Discovery In Cancer Research
Saturday, 20 Mar, 2010 – 1:00 | No Comment

Moffitt Cancer Center and Proteacel LLC have announced that they have entered a licensing agreement under which Proteacel has acquired the exclusive rights to the PORE™ technology for delivery of genes into cells. Genes are the instructions that build cells. Defects in these genes cause disease, such as cancer. In order to understand how these genes work and their involvement in a disease process, researchers must study and modify them. The most common way to study gene function is to transfer the gene into cells…

Duke Cell Therapy Center Benefit From Robertson Foundation Donation
Saturday, 20 Mar, 2010 – 1:00 | No Comment

A $10.2 million commitment from the Robertson Foundation to create a state-of-the-art Translational Cell Therapy Center (TCTC) will advance Duke Medicine’s pioneering cell therapy research and treatment programs for children and adults with cancer, cerebral palsy, stroke and brain injuries suffered at birth. In making the announcement, Victor J…

$1.2 Million Award from NIST Facilitates Groundbreaking Study Of Wireless Body Area Networks
Saturday, 20 Mar, 2010 – 1:00 | No Comment

WPI’s Center for Wireless Information Network Studies (CWINS) has received a three-year, $1.2 million award from the National Institute of Standards and Technology (NIST) to conduct a groundbreaking study of the propagation of radio waves around and through the human body…

Research!America Advocacy Award Honours March Of Dimes
Saturday, 20 Mar, 2010 – 1:00 | No Comment

March of Dimes was honored March 16, 2010, at the 14th Annual Research!America Advocacy Awards event at the Andrew W. Mellon Auditorium in Washington, DC. Jennifer L. Howse, PhD, March of Dimes president, and Anna Eleanor Roosevelt, granddaughter of March of Dimes founder President Franklin Delano Roosevelt, accepted the award. Established by President Roosevelt in 1938 to conquer polio, for more than 72 years March of Dimes has been a leader in improving the health of women and children…